Health Care/Hospital
New contactless health monitoring technology Anura™ enables mobile carriers and handset developers to integrate digital health solution
Monitor blood pressure and predict a person's risk of pre-diabetes in just 30 seconds using only a smartphone video camera BARCELONA, Spain, Feb. 26, 2023 /CNW/ - NuraLogix, a global pioneer of contactless health monitoring showcases a host of new capabilities of its Anura™ platform at MWC 2023...
2023-02-27 03:54
1787
MED-EL Presents: World Cochlear Implant Day 2023 - Over 45 years of major technological advances that enhance hearing and quality of life
INNSBRUCK, Austria, Feb. 24, 2023 /PRNewswire/ -- Today, MED-EL, a leader in implantable hearing solutions, celebrates together with everyone living with and benefiting from cochlear implants. World Cochlear Implant Day pays tribute to the tremendous technological developments since the modern co...
2023-02-24 17:00
2568
HAVAS HEALTH & YOU AND THE AMERICAN PARKINSON DISEASE ASSOCIATION LAUNCH SEXUAL WELLNESS CAMPAIGN PARKINSEX
Activation Advances Nonclinical Strategies for People with Parkinson's to Deepen Intimacy NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Parkinson's disease affects more than ten million people worldwide and the prevalence of sexual dysfunction is disproportionately high in patients, causing partners t...
2023-02-23 22:15
2428
TB Alliance Announces David Norton as Board Chair
NEW YORK, Feb. 23, 2023 /PRNewswire/ -- The TB Alliance Board of Directors has electedDavid Norton as Chairperson of the Board. In this role, David will provide leadership to a diverse Board committed to advancing the vision of TB Alliance. "David Norton has contributed greatly to TB Alliance's ...
2023-02-23 22:00
2282
Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in China
SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Today, Invivoscribe announced that its Shanghai lab in China has received CAP accreditation. The College of American Pathologists (CAP) is a professional organization that accredits clinical laboratories across the world. The CAP accreditation process is ...
2023-02-23 22:00
2459
Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval
World's first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /PRNewswire/ -- Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod ...
2023-02-23 16:00
2323
Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)
STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the treatment of chronic myeloid leukemia (CML) and acute lymp...
2023-02-23 15:02
1622
World-renowned therapist and wellness expert Marisa Peer endorses natural prebiotic Kfibre & Kfibre Pro Synbiotics for advanced gut health management.
Heal the Gut, Heal the Mind SYDNEY, Feb. 23, 2023 /PRNewswire/ -- As a pioneering therapist, speaker, best-selling author, and the founder of Rapid Transformational Therapy (RTT®), Marisa's guiding ethos is centred on simple steps that produce dramatic and life-saving results. One of those step...
2023-02-23 13:31
1781
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
HONG KONG, Feb. 22, 2023 /PRNewswire/ -- Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudi...
2023-02-23 12:26
2277
Dawn Health partners with leading pharmaceutical company to transform chronic care
COPENHAGEN, Denmark, Feb. 23, 2023 /PRNewswire/ -- Dawn Health, a global leader in digital health, today announced a strategic partnership with Novartis, one of the leading medicines companies in the world, to support the development of a platform that enables the effective remote monitoring and ...
2023-02-23 12:16
1579
Trip.com Group aids community recovery through Turkish earthquake relief initiative
SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Trip.com Group, a leading global online travel services provider, is offering aid and assistance to help support victims of the devastatingTurkey-Syria earthquakes that have affected communities throughout the country. Trip.com Group has donated 3,400 eme...
2023-02-23 09:00
1953
EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific
SINGAPORE and CHICAGO, Feb. 22, 2023 /PRNewswire/ -- EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic consulting armEVERSANA® CONSULTING, has been named to Vault's 2023 Top Consulting Ranking in the Asia Pacific (APAC)...
2023-02-22 23:01
2200
Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase
TOKYO, Feb. 22, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity...
2023-02-22 21:05
2286
CRT 2023 selects Syntach Cardiac Support System for Best Innovation Competition
LUND, Sweden, Feb. 22, 2023 /PRNewswire/ -- Syntach AB ("Syntach") is pleased to announce that the Company's Syntach Cardiac Support system (Syntach CS) has been selected for an oral presentation in the Best Innovation Competition to be held during the CRT 2023 annual meeting taking place at the ...
2023-02-22 20:22
2009
Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy
– Based on Results from Phase 3 BOSTON Study, Marketing Authorization Expands Multiple Myeloma Indication – NEWTON, Mass. and FLORENCE, Italy, Feb. 21, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, an...
2023-02-21 23:04
2704
New Study Shows GlycoMark® Test Identifies Prediabetic Individuals with the Highest Risk of Developing Diabetes Before Symptoms Develop
RALEIGH, N.C., Feb. 21, 2023 /PRNewswire/ -- A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard diabetes tests, hemoglobin A1C and glucose – a critical clinical need, as physicians can identify those patients...
2023-02-21 20:30
1785
Organizational-level, Unified and Vendor-neutral Enterprise Imaging and Informatics Drive Effective Digital Transformation
Scalable enterprise-level solutions leverage all data at an enterprise level and can engage with the entire unified longitudinal patient record SAN ANTONIO, Feb. 21, 2023 /PRNewswire/ -- Medical imaging and healthcare digitalization have seen significant advances and evolution in recent years. T...
2023-02-21 16:12
1814
Synbio Tech Inc. and Cosmax Group signed an exclusive cooperation agreement to jointly expand the South Korean probiotics market
KAOHSIUNG, Taiwan, Feb. 21, 2023 /PRNewswire/ -- Synbio Tech Inc. and Cosmax NBT, a major South Korean biotechnology company officially signed an exclusive cooperation agreement to launchLactobacillus plantarum TWK10® probiotic strain inSouth Korea, and announced that TWK10® has been approved as ...
2023-02-21 16:01
2296
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR) announces t...
2023-02-21 14:00
2970
Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand
CAMBRIDGE, Mass., Feb. 21, 2023 /PRNewswire/ -- TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health Group,Australia's s...
2023-02-21 13:00
1880
Week's Top Stories
Most Reposted
MediThinQ Unveils SCOPEYE 3D Micro Surgery Solution; Chris Lee of VentureBlick Assumes Chairmanship
[Picked up by 331 media titles]
2024-05-23 10:00
SINGAPORE'S XSQUARE TECHNOLOGIES SECURES S$10.5M IN SERIES A FUNDING LED BY WAVEMAKER PARTNERS
[Picked up by 326 media titles]
2024-05-23 10:00Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 320 media titles]
2024-05-21 08:00
Mitsui Bussan Secure Directions, Inc. launches Blackpanda IR Retainer, a cyber incident emergency response retainer service
[Picked up by 312 media titles]
2024-05-21 13:00
Unlock the Future of Innovation: Taiwan's Premier Hardware Expo Hits the Global Stage This October
[Picked up by 312 media titles]
2024-05-24 09:41
Most Read
Mitsui Bussan Secure Directions, Inc. launches Blackpanda IR Retainer, a cyber incident emergency response retainer service
2024-05-21 13:00
11350
Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
2024-05-21 08:00
9512
Revolutionising Cardiac Care at Pantai Hospital Kuala Lumpur
2024-05-23 11:22
9257
